Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Medical Device Network on MSN
Prodeon Medical’s BPH implant gains FDA clearance
In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score improvements.
Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology for treating lower urinary ...
The Urocross® Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.
Three new studies from Hospital for Special Surgery (HSS) highlight the use and advantages of osseointegration (OI) for ...
New Canaan and Darien, the top two teams in the GametimeCT Poll, will play for the FCIAC boys ice hockey crown.
In 2025, everyone started being more honest about their plastic surgery. In part, because it’s getting harder to tell who’s had what done. Women are getting a rise out of being able to plausibly deny ...
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and ...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results